Tafsure
Tenofovir Alafenamide 25 mg
Thank you for your enquiry. We will get back to you shortly!
Categories: Hepatitis B Medicine Manufacturer, Hepatology
Description
Description
Tafsure 25
Composition: Tenofovir Alafenamide – 25 mg
Therapeutic Class: Antiviral
Tafsure: Chosen for Hepatitis B Control
Tafsure is a widely prescribed hepatitis B medicine, which is highly effective against Hepatitis B virus.
Aprazer Healthcare: Trusted worldwide for Hepatitis B medicine
Aprazer Healthcare, pioneering innovative treatments for Hepatitis B, is the largest Hepatitis medicine Manufacturer.
- • WHO- GMP certified, assured therapeutic efficacy and quality.
- • Aprazer Healthcare products are available worldwide in 20+ countries.
What is Tafsure?
Tafsure is an antiretroviral medicine used against HBV and HIV-1 infection.
Uses of Tafsure
- • Chronic Hepatitis B
- • HIV-1 infections
How does Tafsure work?
- • It is incorporated as a prodrug, which gets phosphorylated to the active form.
- • Inhibits the reverse transcriptase enzyme.
- • Inhibits virus replication
- • Causes cell death
Benefits
- • Reduces viral load
- • Improves liver functions
- • It can be used in both compensated and decompensated liver disease.
- • Fewer side-effects
- • Potent targeted effect
Common Side Effects
- • Nausea
- • Dizziness
- • Headache
- • Digestive issues
- • Tiredness
- • Diarrhea
Serious Side Effects
- • Lactic Acidosis – unusual pain, breathing issues, irregular heartbeats, abdominal pain
- • Irregular heartbeat
- • Trouble breathing
- • Enlarged fatty liver
Precautions
To be cautiously used in patients with:
- • Kidney disorders
- • HIV – co-infections
- • Liver transplant
- • Elderly patients
Contraindication
- • Not to be used if any previous allergy or hypersensitivity to tenovofir or any excipients.
- • Breastfeeding mothers
- • Pregnant women
- • It cannot be used as a single therapy for HIV patients
Warning
To be used under medical prescription only
Important Safety and Monitoring Information
Regular monitoring of the liver function, renal function, and bone density. Screen for viral load and HIV infections before treatment initiation.
Download Product PDF Attachment